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ABSTRACT
Background Informatics tools may help support
hypertension management.
Objective To design, implement and evaluate a
web-based system for patient anti-hypertensive
medication self-titration.
Methods Study stages included: six focus groups
(50 patients) to identify barriers/facilitators to patient
medication self-titration, software design informed
by qualitative analysis of focus group responses and
a six-month single-arm pilot study (20 patients) to
assess implementation feasibility.
Results Focus groups emphasised patient need to
feel conﬁdent that their own primary care providers
were directly involved and approved of the titration
protocol. Physicians required 3.3  2.8 minutes/
patient to create individualised six-step medication
pathways for once-monthly blood pressure evalu-
ations. Pilot participants (mean age of 51.5  11
years, 45% women, mean baseline blood pressure
139/84  12.2/7.5 mmHg) had ﬁve medication
increases, two non-adherence self-reports, 52 months
not requiringmedication changes, 24 skippedmonths
and 17months with no evaluations due to technical
issues. Four pilot patients dropped out before study
completion. From baseline to study completion,
blood pressure decreased among the 16 patients
remaining in the study (8.0/4.7 mmHg, p = 0.03 for
both systolic and diastolic pressures).
Conclusions Lessons learned included the beneﬁt
of qualitative patient analysis prior to system de-
velopment and the feasibility of physicians design-
ing individual treatment pathways. Any potential
Informatics in Primary Care 2012;20:57–67 # 2012 PHCSG, British Computer Society
RW Grant, JC Pandiscio, H Pajolek et al58
Introduction
Almost one-third of US adults have been diagnosed
with hypertension.1 Despite the availability of a spec-
trum of potent medications, 63% of the US hyperten-
sive population remains suboptimally controlled.2
Poor blood pressure control, in turn, has been shown
to increase the risk for myocardial infarction, renal
disease, stroke and premature death.3 The failure to
satisfactorily address hypertension management within
our current healthcare system requires the develop-
ment of novel care strategies.
To date, most interventions to transform care have
focused primarily on clinicians and clinical practice
systems and have had only marginal beneﬁt.4–7 The
patient, however, is increasingly recognised as the most
important member of the healthcare team.8–10 Prior
research has demonstrated that increasing patients’
involvement in their care improves control of chronic
diseases such as hypertension and diabetes.11–14 A
relatively untested innovation in chronic diseaseman-
agement is to expand the patient’s role in the medi-
cation titration process.
There are few published trials of medication self-
titration for blood pressure control15–17 and limited
experience in implementing such approaches using a
health IT infrastructure. We hypothesised that enabl-
ing patients to implement a predeﬁned hypertension
medication treatment pathway designed by their pri-
mary care physician (PCP) would result in more timely
treatment changes and more eﬀective blood pressure
control. In this report, we describe the design, imple-
mentation and feasibility evaluation of theMedication
Self-titration and Evaluation Program (Med-STEP)
for blood pressure control.
Methods
Conceptual framework for the Med-
STEP system
A review of the published literature indicated two
prevalent barriers to optimal hypertension manage-
ment: (1) clinical inertia (the observation that medi-
cation changes frequently are not made during clinic
visits despite elevated blood pressure levels);18–21 and
(2) lackofpatient engagementwith treatmentplans.22–24
To address these two barriers, we conceived of a
system inwhich: (1) a sequence ofmedication changes
(medication treatment pathway) prespeciﬁed by the
patient’s PCP could be followed independent of clinic
visits; and (2) patients directed their own medication
management through home blood pressure self-mon-
itoring, health IT-supported monthly evaluation of
blood pressure results and medication self-titration
based on PCP-deﬁned medication treatment path-
ways.
Based on this conceptual framework, we created the
Med-STEP intervention. The development process had
three sequential phases: (1) focus group discussions
with patients to identify both perceived beneﬁts and
concerns related to the self-titration of chronic disease
medications; (2) development of the Med-STEP web-
based interface linked to an existing system of home
bloodpressure electronic data collection; and (3) piloting
the system in a single primary care practice to assess its
feasibility prior to wider implementation.
Patient focus groups
Six 90-minute patient focus groups were conducted
from March 2008 to May 2008. Patients diagnosed
with both diabetes and hypertension were recruited
from the primary care practices of the Massachusetts
General Hospital Practice-based Research Network,
Boston, MA.25 All patients were currently taking
hypertension and/or diabetes-relatedmedicines. After
eliciting their views regarding their experiences with
starting and adjusting medications over time, partici-
pants were asked their views about adjusting their own
medical regimens. To help convey the concept, we
showed participants a paper-based example of a med-
ication treatment pathway for a hypothetical patient
depicting a sequence of potential future medication
changes over time (Figure 1). Group interviews were
recorded digitally and transcribed for qualitative con-
tent analysis by three coders using NVivo 7.0 software
(SdGAssociates, London,UK).Themoderator reviewed
the transcripts for accuracy. All participants received a
$40 stipend.
clinical beneﬁts were oﬀset by technical problems,
the tendency for patients to skip their monthly self-
evaluations and drop outs. To be more widely
adopted such systems must eﬀectively generalise
to a wider range of patients and be integrated into
clinical workﬂow.
Keywords: blood pressure, home monitoring,
hypertension, medication adjustment, medication
safety, self-management
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Med-STEP system development
Our health system has an existing informatics plat-
form to help manage home blood pressure readings
(Blood Pressure Connect). Components of this plat-
forminclude: automateddatauploadandcentral storage
from home blood pressure cuﬀs, a patient web-based
interface that graphically represents blood pressure
trends, a provider web-based interface that lists patients
enrolled in the Blood Pressure Connected health pro-
gramme and allows review of individual patient re-
sults, and a secure messaging system for patients and
providers.
With this platform as our starting point, we added
two novel components: a stand-alone medication treat-
ment pathway entry form to input the PCP-deﬁned
treatment algorithms (blood pressure thresholds, med-
ication steps, and any corresponding laboratory safety
monitoring tests if required, see Figure 2); and a new
‘my treatment pathway’ page within the existing
patient Blood Pressure Connect web application to
guide patients through the process of blood pressure
medication adjustment over time (see Figure 3). As
described in the Results, development of these two
new components was informed by the results of the
focus group analysis.
Pilot clinical study
To assess the feasibility of theMed-STEP intervention,
we collaborated with a primary care practice within
our hospital network that expressed interest in inter-
ventions to address quality of hypertension manage-
ment. The ﬁve PCPs in this practice all endorsed the
Med-STEP approach and referred suitable patients to
our study staﬀ. In addition to PCP referrals, we also
used available electronic registry data to identify other
potentially eligible patients. Patient eligibility criteria
included: age > 18 years, elevated blood pressure
(> 140/90 mmHg when last measured, or on treat-
ment and referred by PCP), prescribed 0 or 1 blood
pressuremedications, access to an internet connection
and a compatible analogue telephone land line and
willingness to adjust own medicines. Patients partici-
pating in the original focus group sessions were not
included in the pilot trial.
Figure 1 Paper hand-out used in focus group discussions to explain medication self-titration concept
RW Grant, JC Pandiscio, H Pajolek et al60
The study coordinator met eligible subjects at the
practice to explain the Med-STEP intervention and
obtainwritten informed consent. At this research visit,
subjects also completed a baseline survey designed to
assess their views about hypertension management.
Once a study participant had successfully logged-on
to the website from home and had uploaded at least
one blood pressure reading, a medication treatment
pathway was deﬁned by the subject’s PCP. The prin-
cipal investigator collected the following data from the
PCP to be entered into the medication treatment
pathway algorithm entry form (Figure 2): the mini-
mumnumber of homebloodpressure readings required
before a change would be considered; PCP-designated
blood pressure thresholds for increasing or decreasing
the regimen; and a sequence of four to six medication
changes (and any corresponding laboratory testing)
that this patient would follow. These pathways all
began with ‘Step 1’ (no medicines) and progressed
in single management increments (e.g. dose adjust-
ment or addition of newmedicine) up to ‘Step 6’. Each
patient had a unique pathway and could be enrolled in
the study starting at any step.
During the ﬁrst week for each calendarmonth of the
six-month clinical trial, patients used a home blood
pressure monitoring device to automatically upload
blood pressure readings. Based on the PCP-deﬁned
algorithm, the web-based user interface advised patients
to increase, decrease or remain at their current medi-
cation treatment pathway step. If amedication change
was advised, a prescription was manually sent to the
pharmacy, the medical record was manually updated,
and the research coordinator followed up with the
patient. Pilot trial participants received a $75 stipend.
All phases of the study were approved by the
Massachusetts General Hospital Institutional Review
Board.
Figure 2 Screenshot of the ’medication treatmentpathway’ algorithmentry formused to record PCP-planned
medication changes
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Results
Patient focus groups and software
development
Most focus group participants had a positive im-
pression of the concept underlying the Med-STEP
intervention. The following major themes emerged
from the discussions as beneﬁts of medication self-
titration.
. Awareness: Participants reported that knowing the
sequence of planned medication steps was very
appealing because it would inform them of their
disease process (e.g. ‘... you knowwhether you’re on
the right track or not’) and could reduce anxiety
(e.g. ‘... it eliminates the ... anxiety you have when
the doctor suddenly announces something to you’).
. Engagement: Several participants suggested that the
programme would make them feel more respon-
sible for their hypertension management. One man
stated, ‘It’s becoming participatory medicine’.
Other similar comments included: the programme
would ‘help me to take more responsibility for
myself, to take better care of myself ’ and ‘We are,
after all, all managers of our own health issues ....
And this gives us the chance to do that’.
. Motivation: Many participants expected that the
programme would ultimately lead to better disease
control through increased patient motivation. As
one participant declared, the programme would
provide ‘... incentive to try to get down to that Step 1’.
. Convenience: Another participant suggested that,
since patients would make medication adjustments
between appointments with their physicians, the
programme would eliminate some delay in care
between visits: he noted, ‘Because at times, one is
waiting for the doctor to help ...’; One person said, ‘I
would like if it ... eliminated two out of four
appointments’.
Because of these patient-reported beneﬁts, we were
encouraged to proceed with building the Med-STEP
system. However, despite the many positive com-
ments, participants voiced ﬁve important concerns
that were key to informing the development process.
Table 1 lists the ﬁvemajor concerns (detrimental eﬀect
on doctor–patient relationship, variability of individ-
ual blood pressure readings, diﬃculty in correctly
following a pathway, concern about medication side
eﬀects and the eﬀort required to participate) and the
corresponding design features we implemented to
address the concern. One major issue raised by par-
ticipants was the concern that enrolling in a medi-
cation self-management programme could interfere
with the current relationship the patients enjoyedwith
their PCPs. An innovative feature of our design in
response to this concern was the implementation of
individualised medication treatment pathways that
Figure 3 Screenshot of ’my treatment pathway’ page to guide patients through the process of blood pressure
medication adjustment over time
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were authored by each patient’s PCP rather than using
a single, external treatment algorithm.
The Med-STEP pilot study
Pilot study participants were recruited both by PCP
referral and by direct invitation (see Figure 4 for
patient ﬂow diagram). Of 48 patients successfully
contacted by phone, 20 (42%) consented to partici-
pate (mean age 51.5 years, 45% women, 20% non-
white ethnicity; Table 2). Participants were diagnosed
with hypertension for amean of 6.0 4.3 years, and 17
(85%) were on medicines prior to enrolling in the
pilot. The two factors from the baseline survey that
patients most often cited as motivating their desire to
improve their hypertension management were ‘to
avoid future medical problems’ (all 20 subjects rated
this ‘very important’) and ‘to live a longer and
healthier life’ (19 subjects rated this ‘very important’).
Medication treatment pathways were obtained
from the ﬁve PCPs managing these 20 study subjects.
Excluding the ﬁrst ‘training’ pathway, PCPs required
3.3  2.8 minutes to designate six-step medication
pathways for each patient. These pathways were very
patient speciﬁc,with 19 diﬀerent sequences created for
the 20 subjects.
Med-STEP pilot results
The 20 participants provided 100 patient-months
of data for the Med-STEP algorithm (four patients
withdrew before completing all six months). Patients
successfully evaluated their medication treatment path-
ways for 59 study months, resulting in ﬁve increased
medication dose recommendations (for three patients),
two patient self-reports of non-adherence, and 52
readings that did not require medication changes.
Pathways were not evaluated for 41 patient-months
either because patients chose not to access the system
(24 months) or due to system technical issues (17
months). Common technical problems included: digital
voicemail interferencewith uploading bloodpressures
(n = 5), faulty modems (n = 4) and web password
problems (n = 4). Of interest, for the three patients
with recommendations to ‘step-up’ in their medication
treatment pathway, all three had successful regimen
intensiﬁcationwhen instructed theﬁrst time, but neither
of the two who were instructed to step-up the second
time had successful regimen changes (one subject
declined to increase her dose again and the other
Table 1 Focus group concerns and corresponding design features to address these concerns
Concern Design features
Detrimental eﬀect on doctor–
patient relationship
1. Participant continues to see his/her physician at usual intervals
(i.e. home monitoring would not take the place of visits)
2. PCPs participate in selection of programme participants
3. Each participant’s ‘medication treatment pathway’ is designed by
his/her own PCP
Variability in blood pressure
readings
1. Home monitoring with treatment decisions based on the average
of several readings (minimum number chosen by PCP)
2. Automated blood pressure cuﬀ (reduces user errors associated
with manual measurement)
Correctly following pathway 1. Automated uploads of blood pressure measurements
2. Pathway uploaded to website
3. Algorithm run by computer
4. Veriﬁed by physician principal investigator
Medication side-eﬀects 1. All medications chosen by the PCP
2. Possible side-eﬀects listed in the pathway; instructed to call
primary care practice about any side-eﬀects
3. No increased risk from side-eﬀects relative to usual care
Too much eﬀort/doesn’t want
responsibility
1. Highly selective programme
2. Automated home monitoring device and website pathway
3. Subject continues to see his/her physicians at usual intervals (i.e.
home monitoring would not take the place of visits)
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subject did not obtain the laboratory testing required
prior to making the change).
There was a signiﬁcant decrease in blood pressure
among the 16 participants who completed the study
(systolic blood pressure declined by 8.0 mmHg, p =
0.03; diastolic blood pressure declined by 4.7 mmHg,
p = 0.025). The three subjects with medication in-
creases had an average blood pressure decline of 8.7/
5.7 mmHg.
End-of-study surveys were collected from 18 par-
ticipants. Most of these patients (16/18) agreed that
the system was useful to help them manage their
hypertension and 17/18would recommend the system
to others, although several participants reported their
frustration with technical issues.
Discussion
We designed a web-based system linking home blood
pressure monitoring to PCP-deﬁned medication
treatment pathways with the goal of improving blood
pressure control. In a six-month pilot study, we found
that implementation of the systemwas feasible butwas
limited by technical issues, patient reluctance to make
changes or self-monitor and relatively low enrolment
rates.
Although we showed the system to be feasible for
blood pressure management, there were several key
lessons learned that we believe are crucial for sub-
sequent eﬀorts to generalise this model of care.
Patient–PCP connection
In response to concerns raised by many of our focus
group participants, we designed our programme to
Figure4 Pilot clinical trial enrolmentﬂowdiagram.BP,bloodpressure;HTN,hypertension; SSN, social security
number
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strengthen rather than obscure the PCP’s role. To
achieve this goal, we opted to have PCPs design their
patients’ medication treatment pathways rather than
rely on published algorithms. We found that PCPs
were able to quickly and eﬃciently design unique
pathways for each patient. This process also increased
PCP and patient conﬁdence in the programme. Pilot
participants conﬁrmed the importance of their PCP
knowing that changes were being made. Our results
suggest that this strategy may have advantages over
using predeﬁned treatment algorithms.
Limitations of the ‘patient
engagement’ model
It has become widely accepted that increasing patient
engagement with their care can improve clinical out-
comes.26,27 While our study does not disprove this
principle, we found that several subjects were reluc-
tant to make changes even when indicated by their
PCP-designed medication treatment pathways. This
result suggests that even among consented study par-
ticipants, many patients with asymptomatic diseases
conveying relatively minor short-term clinical risks
may not feel comfortablemaking repeatedmedication
changes over a relatively short time. It must be noted
that patients in our pilot study were not directly
involved in the design of their medication pathways.
Thus, while pilot participants had an active role in
their hypertension management, the Med-STEP pilot
did not represent a truly collaborative, shared decision-
makingmodel of care as recommended by the chronic
care model. Future research is needed into the poten-
tial beneﬁts (and increased time requirements) of a
shared decision-making approach.
Technology failings
Because of issues with connectivity and password
access, several participants experienced repeated tech-
Table 2 Characteristics of patients participating in the Med-STEP pilot study (n = 20)
Characteristic
Women, n (%) 9 (45)
Age, years  SD 51.5  11
Non-white ethnicity, n (%) 4 (20)
Employed, n (%) 15 (75)
College educated, n (%) 15 (75)
Household annual income > $100 000, n (%) 4 (25)
Duration of hypertension  SD (years) 6.0  4.3
Baseline blood pressure  SD (mmHg) 139/84  12.2/7.5
Currently prescribed antihypertensive medicines,
n (%)
17 (85)
Baseline survey responses, n (%):
Days taking blood pressure medicines in prior week 6.9  0.3 days
Conﬁdence in being able to control blood pressure 5 (25) ‘very conﬁdent’; 11 (55) ‘conﬁdent’
Importance of improving blood pressure 18 (90) ‘very important’; 2 (10) ‘important’
Generally feel conﬁdent in using new technology 13 (65) ‘strongly agree’; 7 (35) ‘agree’
Like to be involved in making decisions about
medical treatment
13 (65) ‘strongly agree’; (30) ‘agree’
Believe it is primarily the patient’s responsibility to
look after hypertension
10 (50) ‘strongly agree’; 9 (45) ‘agree’
Prefer to leave decisions about hypertension
treatment to provider
1 (5) ‘strongly agree’; 6 (30) ‘agree’
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nical problems, which led to withdrawal from the
programme. This is not a great insight, but it under-
scores the importance of implementing simple, high-
ﬁdelity health IT systems to avoid losing patient or
provider buy-in.
Workﬂow
The primary care practice and associated PCPs were
willing to participate in the study because the research
team assumed responsibility for many of the tasks
generated by the programme (e.g. programme enrol-
ment and patient education, updating the clinic rec-
ord when changes were made, ordering and following
up the results of safety labs triggered by medication
changes, and sending new prescriptions to the patient’s
pharmacy). While several of these functions could be
automated in a more advanced version of the pro-
gramme, the clinical beneﬁt has to justify themodel of
non-visit-based care. With health payment reform,
newer models of care (e.g. accountable care organis-
ations) may be amenable to this programme.28 In
addition, current care systems may lack the ﬂexibility
required for more collaborative care given the ad-
ditional time that would be required to create medi-
cation pathways using a PCP-patient shared decision-
making approach.
To date, there have been two small pilot studies of
patient medication self-titration16,17 and one recent,
large randomised trial.15 The earliest study random-
ised 31 hypertensive subjects to home blood pressure
monitoring and medication self-titration using a
paper-based algorithm.17 This initial pilot, conducted
in 1997, reported modest blood pressure beneﬁts
but did not appear to be subsequently evaluated or
adopted on a larger sale. A second pilot study con-
ducted more recently in France focused on feasibility
and safety.16 This short-term study (only eight weeks)
combined home blood pressure monitoring, tele-
medicine contact with the research team and a single
titration protocol for all participants. Patients on non-
study medicines at study entry were converted to the
study protocol. The authors report overall satisfaction
with the programme by participants and decline from
baseline in mean blood pressure by eight weeks.
Most recently, McManus et al reported the re-
sults of a large randomised trial (telemonitoring
and self-management in the control of hypertension
[TASMINH2]) conducted in the UK involving 24
primary care practices and 527 participants with
hypertension (blood pressure > 140/90mmHgdespite
anti-hypertensive treatment).15 As in our study,medi-
cation titration parameters were deﬁned by patients’
PCPs, although in TASMINH2 the treatment path-
ways were limited to two medication titrations over
the 12-month study and changes were only made if
blood pressure readings were elevated for two con-
secutive months. The protocol of medication adjust-
ment was less aggressive than themonthly assessments
in theMed-STEP study. Based on exit interviews from
Med-STEP participants, we believe that fewer changes
over a greater period of time (as with TASMINH2)
may actually improve patient participation. Imple-
mentation of the TASMINH2 trial was resource in-
tensive. Researchers invited 7637 patients to participate,
and screened 1650 patients accepting the invitation to
randomise 527 participants (of whom only 480 were
ultimately included in the ﬁnal analysis). Participants
each received two intensive training sessions prior to
enrolment to ensure competence in blood pressure
measurement and data transfer via modem. Re-
searchers also scheduled visits at 6 and 12 months
for data collection.
The results from our study and from TAMSINH2
and other pilot trials lead to several general con-
clusions and suggest important next steps. The data
show that patients who can successfully self-titrate
their blood pressure medications will likely have
improved blood pressure control. Given the high
prevalence and signiﬁcant clinical impact of hyper-
tension, eﬀorts to implement this approach among
patients with inadequately controlled blood pressure
deserve strong consideration. As with many inno-
vations that involve new technology and new patterns
of care, however, translation of this concept into usual
care will require addressing signiﬁcant barriers to
change such as current visit-based payment mechan-
isms, provider workﬂow and team composition,29
reliability of technology, and patient willingness to
adopt a greater role in their disease management.
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